NEW YORK (GenomeWeb) – Bruker's board has authorized a share repurchase program, according to a document filed with the US Securities and Exchange Commission this week.

According to the firm's Form 8-K filed May 20, Bruker may repurchase shares of its common stock in order to offset the dilution of its stock resulting from the granting of option awards or restricted stock grants.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.